Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia...
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial
About this item
Full title
Author / Creator
Gaborit, Benjamin , Vanhove, Bernard , Vibet, Marie-Anne , Le Thuaut, Aurélie , Lacombe, Karine , Dubee, Vincent , Ader, Florence , Ferre, Virginie , Vicaut, Eric , Orain, Jéremie , Le Bras, Morgane , Omnes, Anne , Berly, Laetitia , Jobert, Alexandra , Morineau-Le Houssine, Pascale , Botturi, Karine , Josien, Régis , Flet, Laurent , Degauque, Nicolas , Brouard, Sophie , Duvaux, Odile , Poinas, Alexandra , Raffi, François , Dailly, Eric , Guimard, Thomas , Braudeau, Cécile , Malvy, Denis , Faucher, Jean-François , Illes Hajnal, Gabriela , Vareil, Marc-Olivier , Roncato-Saberam, Mariam , Vacher, Laurent , Biron, Charlotte , Lefebvre, Maeva , Gallot, Géraldine , Le Turnier, Paul , Deschanvres, Colin , Lecomte, Raphael , Chauveau, Marie , Lecompte, Anne-sophie , Grégoire, Matthieu , Bellouard, Ronan , Deslandes, Guillaume , Ouazene, Zineb , Bollens, Diane , Chiarabani, Thibault , Krause-Le Garrec, Jessica , Becker, Agathe , Chauvelot, Pierre , Conrad, Anne , Ferry, Tristan , Miailhes, Patrick , Pouderoux, Cécile , Roux, Sandrine , Triffault-Fillit, Claire and POLYCOR study group
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Early inhibition of entry and replication of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a very promising therapeutic approach. Polyclonal neutralizing antibodies offers many advantages such as providing immediate immunity, consequently blunting an early pro-inflammatory pathogenic endogenous antibody response and lack of dr...
Alternative Titles
Full title
Evaluation of the safety and efficacy of XAV-19 in patients with COVID-19-induced moderate pneumonia: study protocol for a randomized, double-blinded, placebo-controlled phase 2 (2a and 2b) trial
Authors, Artists and Contributors
Author / Creator
Vanhove, Bernard
Vibet, Marie-Anne
Le Thuaut, Aurélie
Lacombe, Karine
Dubee, Vincent
Ader, Florence
Ferre, Virginie
Vicaut, Eric
Orain, Jéremie
Le Bras, Morgane
Omnes, Anne
Berly, Laetitia
Jobert, Alexandra
Morineau-Le Houssine, Pascale
Botturi, Karine
Josien, Régis
Flet, Laurent
Degauque, Nicolas
Brouard, Sophie
Duvaux, Odile
Poinas, Alexandra
Raffi, François
Dailly, Eric
Guimard, Thomas
Braudeau, Cécile
Malvy, Denis
Faucher, Jean-François
Illes Hajnal, Gabriela
Vareil, Marc-Olivier
Roncato-Saberam, Mariam
Vacher, Laurent
Biron, Charlotte
Lefebvre, Maeva
Gallot, Géraldine
Le Turnier, Paul
Deschanvres, Colin
Lecomte, Raphael
Chauveau, Marie
Lecompte, Anne-sophie
Grégoire, Matthieu
Bellouard, Ronan
Deslandes, Guillaume
Ouazene, Zineb
Bollens, Diane
Chiarabani, Thibault
Krause-Le Garrec, Jessica
Becker, Agathe
Chauvelot, Pierre
Conrad, Anne
Ferry, Tristan
Miailhes, Patrick
Pouderoux, Cécile
Roux, Sandrine
Triffault-Fillit, Claire
POLYCOR study group
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_c0680748f60346049915c615da5ecaca
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_c0680748f60346049915c615da5ecaca
Other Identifiers
ISSN
1745-6215
E-ISSN
1745-6215
DOI
10.1186/s13063-021-05132-9
